Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor

Transfusion

Volumn 52, Issue 9, 2012, Pages 1999-2006

  Blaich, Annette ^a,b,c,d   Manz, Michael ^a,b,c,d   Dumoulin, Alexis ^a,b,c,d   Schüttler, Christian G ^a,b,c,d   Hirsch, Hans H ^a,b,c,d   Gerlich, Wolfram H ^a,b,c,d   Frei, Reno ^a,b,c,d  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b St Clara Hospital   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; FRESH FROZEN PLASMA; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CASE REPORT; ESOPHAGUS VARICES; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEPATITIS B; HEPATITIS B VIRUS; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; SEROCONVERSION; VIRUS REACTIVATION;

HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MUTATION; TISSUE DONORS; VIRUS ACTIVATION;

EID: 84865750449     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03537.x     Document Type: Article

References (22)

1. Gerlich WH, Bremer C, Saniewski M, Schüttler CG, Wend UC, Willems WR, Glebe D,. Occult hepatitis B virus infection: detection and significance. Dig Dis 2010; 28: 116-25.
2. Cholongitas E, Papatheodoridis GV, Burroughs AK,. Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol 2010; 52: 272-9.
3. Avelino-Silvo VI, D'Albuquerque LA, Bonazzi PR, Song AT, Miraglia JL, de Brito Neves A, Abdala E,. Liver transplant from anti-HBc-positive, HBsAg-negative donor into HBsAg-negative recipient: is it safe? A systematic review of the literature. Clin Transplant 2010; 24: 735-46.
4. Bremer CM, Saniewski M, Wend UC, Torres P, Lelie PN, Gerlich WH, Glebe D,. Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion 2009; 49: 1621-9.
5. Danzinger-Isakov L, Kumar D,; the AST Infectious Diseases Community of Practice. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2009; 9 Suppl 4: S258-S262.
6. Keeffe EB,. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. Am J Med 2005; 118 Suppl 10A: 21S-7S.
7. Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP,. Prevention of hepatitis A through active or passive immunization: recommendation of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2006; 55: 1-23.
8. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW,; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, Part II: immunization of adults. MMWR Recomm Rep 2006; 55: 1-33.
9. Keeffe EB,. Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. Trans Am Clin Climatol Assoc 2006; 117: 227-38.
10. Bauer T, Günther M, Bienzle U, Neuhaus R, Jilg W,. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells. Liver Transpl 2007; 13: 434-42.
11. Saab S, Waterman B, Chi AC, Tong MJ,. Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review. Liver Transpl 2010; 16: 300-7.
12. Shouval D,. Adoptive transfer of immunity to HBV in liver transplant patients: a step forward toward the proof of concept for therapeutic vaccination or a transient immunologic phenomen? Liver Transpl 2007; 13: 14-7.
13. Niederhauser C, Taleghani BM, Graziani M, Stolz M, Tinguely C, Schneider P,. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus? Swiss Med Wkly 2008; 138: 134-41.
14. Mele A, Tancredi F, Romanò L, Giuseppone A, Colucci M, Sangiuolo A, Lecce R, Adamo B, Tosti ME, Taliani G, Zanetti AR,. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001; 184: 905-8.
15. Avellõn A, Echevarria JM,. Frequency of hepatitis B virus "a" determinant variants in unselected Spanish chronic carriers. J Med Virol 2006; 78: 24-36.
16. Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, Di Vita G, Scisca C, Squadrito G, Pollicino T,. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 2008; 48: 743-6.
17. Lim YA, Hyun BH, Kim DY,. Effect of transfusion of fresh-frozen plasma on recipient's antibodies to hepatitis B surface antigen and hepatitis B surface antigen status in countries where hepatitis B is endemic. Vox Sang 2002; 83: 209-13.
18. Torbenson M, Thomas DL,. Occult hepatitis B. Lancet Infect Dis 2002; 2: 479-86.
19. Kantelhardt VC, Schwarz A, Wend U, Schüttler CG, Willems WR, Trimoulet P, Fleury H, Gerlich WH, Kann M,. Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigen. J Clin Virol 2009; 46: 124-8.
20. Gujar SA, Michalak TI,. Primary occult hepadnavirus infection induces virus-specific T-cell and aberrant cytokine responses in the absence of antiviral antibody reactivity in the woodchuck model of hepatitis B virus infection. J Virol 2009; 83: 3861-76.
21. Avettand-Fenoel V, Thantibodyut D, Katlama C, Poynard T, Thibault V,. Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection. J Clin Microbiol 2006; 44: 2250-3.
22. Possehl C, Repp R, Heermann KH, Korec E, Uy A, Gerlich WH,. Absence of free core antigen in anti-HBc negative viremic hepatitis B carriers. In:, DeBac C, Gerlich WH, Taliani G, editors. Chronically evolving viral hepatitis (Archives of virology. Supplementa). Berlin: Springer; 1992. p. 39-41.